| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |